Skip to content
Medical Health Aged Care

Monash Expert: Understanding Australia’s COVID-19 epidemics

Monash University < 1 mins read

As the world deals with a new Covid-19 variant, XEC, new Monash University-led research has shown how important short-lived immunity and immune-escape of new variants have been to driving waves of transmission in Australia.

Available to comment:

Associate Professor James Trauer, Head of the Epidemiological Modelling Unit for the School of Public Health and Preventive Medicine
Contact: +613 9903 4840, or media@monash.edu  
Read more of Associate Professor Trauer’s commentary in Monash Lens.

  • The status of COVID-19 in Australia now
  • The likely impact of COVID-19 moving forward
  • The need for continued vaccination

The following can be attributed to Associate Professor Trauer:

“Our research showed that Australia's major Omicron waves in 2022 were driven by substantial immune-escape of new variants combined with immunity that protected against infection only lasting around three to four months.

“The ‘shadow lockdown’ in summer 2021-2022, when Australians reduced their social interaction in the absence of a government mandate, likely protected us from a considerably larger first epidemic wave. Only around 20 to 40 per cent per cent of all COVID-19 episodes were notified through our surveillance systems, even with our highest levels of testing.

“I think ATAGI’s current guidelines strike the right balance and that people should get vaccinated if they are at-risk and eligible. As the virus continues to evolve, the more recent vaccines are more protective against the current variants - so it's more important if you haven't been vaccinated since the start of last year.” 

For more Monash media stories visit our news & events site: monash.edu/news
For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or media@monash.edu

More from this category

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:
  • Medical Health Aged Care
  • 14/01/2025
  • 16:16
Dementia Australia

Memory Walk & Jog is coming back to Redcliffe!

Dementia Australia’s largest annual fundraising event, Memory Walk & Jog, is heading back to Redcliffe to help raise much-needed funds in support of people living with dementia, their families and carers. This year walkers, runners and joggers will set off on Saturday 24 May at Scarborough Beach Park, Redcliffe to raise money, awareness and to get active for their brain health. Dementia Australia Ambassador Wally Lewis AM laid down a challenge for the community of Redcliffe calling on more people than ever to get involved in Memory Walk & Jog by either walking, running, volunteering, donating or supporting 2025 participants.…

  • Contains:
  • Medical Health Aged Care
  • 14/01/2025
  • 15:38
Dementia Australia

Memory Walk & Jog is headed to Coolum for the first time!

Dementia Australia’s largest annual fundraising event, Memory Walk & Jog, is heading to Coolum for the very first time to help raise funds in support of people living with dementia, their families and carers. This year walkers, runners and joggers will set off on Saturday 7 June at Tickle Park,Coolum Beach to raise money, awareness and to get active for their brain health. Dementia Australia Ambassador Wally Lewis AM laid down a challenge for the community ofCoolum calling on everyone to get involved in Memory Walk & Jog by either walking, running, volunteering, donating or supporting 2025 participants. “Queenslanders have…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.